BHI News Section Archives - Page 81 of 1182

News

January 7, 2022

NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board

GAITHERSBURG, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…

Super User

Love0

News

January 7, 2022

South Duvall Takes Next Step to Bring 45,000 Square Feet of Lab Space to Rockville

ROCKVILLE, Maryland – January 6, 2022 South Duvall today announced that it has submitted construction…

Super User

Love0

Cursor and Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability Horizon Therapeutics plc

News

January 7, 2022

Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability | Horizon Therapeutics plc

DUBLIN--(BUSINESS WIRE)--Jan. 6, 2022-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has signed…

Super User

Love0

News

January 7, 2022

REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy

ROCKVILLE, Md., Jan. 6, 2022 /PRNewswire/ -- Potential one-time gene therapy for the treatment of…

Super User

Love0

News

January 5, 2022

Zalgen Labs’ move to Frederick is another sign of the BioHealth Capital Region’s strengths

Maryland biotech company Zalgen Labs has moved to Frederick, illustrating the magnetism of the biotech hub for…

Super User

Love0

News

January 5, 2022

BioBuzz: Charlottesville’s Molecular Biologicals is Changing the Game in Wound Care BioBuzz: Charlottesville’s Molecular Biologicals is Changing the Game in Wound C

Imagine you’re working outside and accidentally cut your foot on a protruding stick you didn’t…

Super User

Love0

News

January 4, 2022

Dr. James Crowe, Director of the Vanderbilt Vaccine Center Visits Bloomberg Markets: America, and CNBC’s Squawk Box

On this snowy start to 2022, I wanted to share with you two interviews with…

Super User

Love0

News

January 3, 2022

BHI Recruiting a Senior Analyst, Immediate Opening.

BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in…

Super User

Love0

News

January 3, 2022

Best Tech Innovation Companies Exhibiting at the CES 2022

Global health tech companies are queueing up for one of the world’s largest in-person events…

Super User

Love0

News

January 3, 2022

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies

Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants…

Super User

Love0

BHI News Section

NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board

South Duvall Takes Next Step to Bring 45,000 Square Feet of Lab Space to Rockville

Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Development and Technical Operations Capability | Horizon Therapeutics plc

REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy

Zalgen Labs’ move to Frederick is another sign of the BioHealth Capital Region’s strengths

BioBuzz: Charlottesville’s Molecular Biologicals is Changing the Game in Wound Care BioBuzz: Charlottesville’s Molecular Biologicals is Changing the Game in Wound C

Dr. James Crowe, Director of the Vanderbilt Vaccine Center Visits Bloomberg Markets: America, and CNBC’s Squawk Box

BHI Recruiting a Senior Analyst, Immediate Opening.

Best Tech Innovation Companies Exhibiting at the CES 2022

Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies

About BioHealth Innovation

Contact

Connect